Ontozry Treatment Initiation Pack 12.5 mg tablets and 25 mg film-coated tablets

Manufacturer/MA Holder: Angelini Pharma UK-I Limited
MA Number: PLGB 56215/0007
Drug Safety Category

Unclassified

Active Ingredient

Cenobamate

Formulation

Tablet & Film Coated Tablet

Strength

12.5mg & 25mg

Licensed for use with feeding tube

No

Confirmed as carbohydrate free

No

Length/Diameter

6.3mm

SPC URL

Open SPC

Excipients of concern

Lactose39.7mg in the 12.5mg tablet
Lactose79.3mg in the 25mg tablet